Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-riboseor Ca2+ concentrations is involved in autoregulation of oxytocin secretionin the hypothalamus and posterior pituitary in male mice

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 50-55

  Lopatina, Olga ^a,b,c   Liu, Hong Xiang ^a,b   Amina, Sarwat ^a,b   Hashii, Minako ^b,c   Higashida, Haruhiro ^a,b,c  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ADP ribosyl cyclase; Calcium; CD38; Cyclic ADP ribose; Oxytocin; Protein kinase C; Social behavior

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; ARGIPRESTOCIN; CALCIUM ION; CALPHOSTIN C; CD38 ANTIGEN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; OXYTOCIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; HYPOTHALAMUS; MALE; MEMBRANE BINDING; MOUSE; NERVE ENDING; NEUROHYPOPHYSIS; NONHUMAN; OXYTOCIN RELEASE; POSITIVE FEEDBACK; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

ADP-RIBOSYL CYCLASE; ANIMALS; CALCIUM; CYCLIC ADP-RIBOSE; HYPOTHALAMUS; MALE; MICE; MICE, INBRED ICR; OXYTOCIN; PITUITARY GLAND, POSTERIOR; PRESYNAPTIC TERMINALS; TIME FACTORS;

EID: 71549168595     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.012     Document Type: Article

References (40)

1. Adan R.A.H., Van Leeuwen F.W., Sonnemans M.A.F., Brouns M., Hoffman G., Verbalis J.G., and Burbach J.P.H. Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization. Endocrinology 136 (1995) 4022-4028
2. 2+ transients in human myometrium cells. Endocrinology 145 (2004) 881-889
3. Boittin F.X., Dipp M., Kinnear N.P., Galione A., and Evans A.M. Vasodilation by the calcium-mobilizing messenger cyclic ADP-ribose. The Journal of Biological Chemistry 278 (2003) 9602-9608
4. Ceni C., Pochon N., Villaz M., Muller-Steffner H., Schuber F., Baratier J., De Waard M., Ronjat M., and Moutin M.J. The CD38-independent ADP-ribosyl cyclase from mouse brain synaptosomes: a comparative study of neonate and adult brain. Biochemical Journal 395 (2006) 417-426
5. Domes G., Heinrichs M., Michel A., Berger C., and Herpertz S.C. Oxytocin improves "mind-reading" in humans. Biological Psychiatry 61 (2007) 731-733
6. Donaldson Z.R., and Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322 (2008) 900-904
7. Freund-Mercier M.J., Stoeckel M.E., and Klein M.J. Oxytocin receptors on oxytocin neurons: histoautoradiographic detection in the lactating rat. The Journal of Physiology (Lond.) 480 (1994) 155-161
8. Gimpl G., and Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiological Reviews 81 (2001) 629-683
9. Graeff R.M., Franco L., De Flora A., and Lee H.C. Cyclic GMP-dependent and -independent effects on the synthesis of the calcium messengers cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate. The Journal of Biological Chemistry 273 (1998) 118-125
10. Graeff R., and Lee H.C. A novel cycling assay for cellular cADP-ribose with nanomolar sensitivity. The Biochemical Journal 361 (2002) 379-384
11. Graeff R.M., Walseth T.F., Fryxell K., Branton W.D., and Lee H.C. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. The Journal of Biological Chemistry 269 (1994) 30260-30267
12. 2+ signalling in rodent NG108-15 neuroblastoma cells. Neuroscience Research 57 (2007) 339-346
13. Higashida H., Egorova A., Higashida C., Zhong Z.G., Yokoyama S., Noda M., and Zhang J.S. Sympathetic potentiation of cyclic ADP-ribose formation in rat cardiac myocytes. The Journal of Biological Chemistry 274 (1999) 33348-33353
14. Higashida H., Salmina A.B., Olovyannikova R.Y., Hashii M., Yokoyama S., Koizumi K., Jin D., Liu H.X., Lopatina O., Amina S., Islam M.S., Huang J.J., and Noda M. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochemistry International 51 (2007) 192-199
15. Higashida H., Yokoyama S., Hashii M., Taketo M., Higashida M., Takayasu T., Ohshima T., Takasawa S., Okamoto H., and Noda M. Muscarinic receptor-mediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes. The Journal of Biological Chemistry 272 (1997) 31272-31277
16. Hlubek M., Tian D., and Stuenkel E.L. Mechanism of alpha-latrotoxin action at nerve endings of neurohypophysis. Brain Research 992 (2003) 30-42
17. Hollander E., Novotny S., Hanratty M., deCaria R.Y.C., and Aronowitz B. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28 (2003) 193-198
18. Jin D., Liu H.X., Hirai H., Torashima T., Nagai T., Lopatina O., Shnayder N.A., Yamada K., Noda M., Seike T., Fujita K., Takasawa S., Yokoyama S., Koizumi K., Shiraishi Y., Tanaka S., Hashii M., Yoshihara T., Higashida K., Islam M.S., Yamada N., Hayashi K., Noguchi N., Kato I., Okamoto H., Matsushima A., Salmina A., Munesue T., Shimizu N., Mochida S., Asano M., and Higashida H. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446 (2007) 41-45
19. Jin D., Liu H.X., Lopatina O., Hashii M., Amina S., Shuto S., Shiraishi Y., Tanaka S., and Higashida H. OT released from mouse hypothalamus and nerve endings by extracellular application of beta-NAD+ and cyclic ADP-ribose. Nature Protocols Network (2007) 10.1038/nprot.2007.214
20. i, and insulin secretion. The Journal of Biological Chemistry 274 (1999) 1869-1872
21. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., and Fehr E. Oxytocin increases trust in humans. Nature 435 (2005) 673-676
22. Lambert R.C., Dayanithi G., Moos F.C., and Richard P. A rise in the intracellular Ca2+ concentration of isolated rat supraoptic cells in response to oxytocin. The Journal of Physiology 478 (1994) 275-287
23. Lee H.C. Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annual Review of Pharmacology and Toxicology 41 (2001) 317-345
24. Liu H.X., Lopatina O., Higashida C., Tsuji T., Kato I., Takasawa S., Okamoto H., Yokoyama S., and Higashida H. Locomotor activity, ultrasonic vocalization and oxytocin levels in infant CD38 knockout mice. Neuroscience Letters 448 (2008) 67-70
25. McGregor I.S., Callaghan P.D., and Hunt G.E. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?. British Journal of Pharmacology 154 (2008) 358-368
26. Moos F., Freund-Mercier M.J., Guerné Y., Guerné J.M., Stoeckel M.E., and Richard P. Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. Journal of Endocrinology 102 (1984) 63-72
27. Neumann I., Douglas A.J., Pittman Q.J., Russell J.A., and Landgraf R. Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events. Journal of Neuroendocrinology 8 (1996) 227-233
28. Neumann I.D. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. Journal of Neuroendocrinology 20 (2008) 858-865
29. Neumann I., Koehler E., Landgraf R., and Summy-Long J. An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats. Endocrinology 134 (1994) 141-148
30. OuYang W., Wang G., and Hemmings Jr. H.C. Distinct rat neurohypophysial nerve terminal populations identified by size, electrophysiological properties and neuropeptide content. Brain Research 1024 (2004) 203-211
31. 2+ level and motility of lymphokine-activated killer cells. Journal of Biological Chemistry 280 (2005) 2888-2895
32. Richard P., Moos F., and Freund-Mercier M.J. Central effects of oxytocin. Physiological Reviews 71 (1991) 331-370
33. 2+ clearance mechanisms in neurohypophysial terminals of the rat. Cell Calcium 37 (2005) 45-56
34. Sheikh S.P., Feldthus N., Orkild H., Göke R., McGregor G.P., Turner D., Møller M., and Stuenkel E.L. Neuropeptide Y2 receptors on nerve endings from the rat neurohypophysis regulate vasopressin and oxytocin release. Neuroscience 82 (1998) 107-115
35. Skuse D.H., and Gallagher L. Dopaminergic-neuropeptide interactions in the social brain. Trends in Cognitive Science 13 (2009) 27-35
36. Sternfeld L., Krause E., Guse A., and Schulz I. Hormonal control of ADP-ribosyl cyclase activity in pancreatic acinar cells from rats. The Journal of Biological Chemistry 278 (2003) 33629-33636
37. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., and Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochemistry Biophysical Research Communications 135 (1986) 397-402
38. Troadec J.D., Thirion S., Nicaise G., Lemos J.R., and Dayanithi G. ATP-evoked increases in [Ca2+]i and peptide release from rat isolated neurohypophysial terminals via a P2X2 purinoceptor. Journal of Physiology 511 (1998) 89-103
39. Young L.J., Muns S., Wang Z., and Insel T.R. Changes in oxytocin receptor mRNA in rat brain during pregnancy and the effects of estrogen and interleukin-6. Journal of Neuroendocrinology 9 (1997) 859-865
40. Zak P.J., Stanton A.A., and Ahmadi S. Oxytocin increases generosity in humans. PLoS ONE 2 (2007) e1128